System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Jürgen Harreiter is an expert in Endocrinology at Landesklinikum Scheibbs (Austria). As of October 2026, ScienceLeadR ranks Jürgen Harreiter in the top 1% of experts worldwide for Diabetes Mellitus, Glucose Metabolism Disorders and Diabetes, Gestational. Jürgen Harreiter has authored 157 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 1 of them ongoing. SLR score: 452 (community average: 125). How the SLR is computed.

LeadR Profile

Jürgen Harreiter Landesklinikum Scheibbs Austria
452 ScienceLeadR Reputation 452

Unlock

Register Login
Network Map

Endocrinology

Subspecialties: Obstetrics - Gynecology - Pediatrics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2011 - 2026
Source: PubMed

Medical University of Vienna

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 157

Citations

Citations: 6 388 1st author: 22 Last author: 16 Unique author: 0

Main journals

Wien Klin Wochenschr 23
Diabetes Care 10
Diabetes Res Clin Pract 5
Diabetologia 5
Endocrine Abstracts 5

Best Journals

N Engl J Med 1
Nature 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Maternal and Neonatal Complications in Pregnant Women With Polyendocrine Metabolic Ovarian Syndrome: A Nested Prospective Cohort Study.
PMID 42747940 — diabetes mellitus, pregnant women, diabetes, gestational, pregnancy, parturition, ovary, cohort studies		Diabetes Care20260
Association Between Relative Cord Hyperleptinemia and Offspring Outcomes in Pregnant Women With Overweight or Obesity.
PMID 42629609 — diabetes mellitus, pregnant women, diabetes, gestational, pregnancy, parturition, leptin, obesity, overweight, infant		Pediatr Obes20260
Vitamin D Deficiency During Pregnancy Is Associated With Greater LDL-C Increase, Elevated β-Hydroxybutyrate and Altered Neonatal Metabolic Markers-A Secondary, Pooled Analysis of the Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes Prevention Trial (DALI).
PMID 42594354 — diabetes mellitus, vitamin d, diabetes, gestational, pregnancy, life style, blood, vitamins, pregnancy outcome, ketones, obesity, overweight, vitamin d deficiency		Endocrinol Diabetes Metab20260
[Diabetes mellitus-definition, classification, diagnosis, screening and prevention (Update 2026)].
PMID 42162460 — diabetes mellitus, classification, diagnosis, diabetes mellitus, type 2		Wien Klin Wochenschr20260
[Obesity and type 2 diabetes mellitus (Update 2026)].
PMID 42162469 — diabetes mellitus, glucagon-like peptide 1, obesity, therapeutics, diabetes mellitus, type 2		Wien Klin Wochenschr20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 3
Phase 1 1
Phase 2 1
Phase 3 1
Phase 4 1

By status:

Completed 4
Recruiting 2
Unknown 1

By type:

Interventional 6
Observational 1

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 1
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight Obese Men With T2DM or Prediabetes and Hypogonadism
NCT03851627 — diabetes mellitus, hypogonadism, insulin, eunuchism, non-alcoholic fatty liver disease, glucose intolerance, liver, solutions, testosterone, prediabetic state, obesity, methyltestosterone, therapeutics, overweight, fatty liver, diabetes mellitus, type 2, lipids, male, men		Phase 4Recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS